Reardon Andrew
Insider CIK 1950232 · LGND See Remarks
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2026-10-02 | 2026-10-06 | 340 | — | $0 | 29,104 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2026-10-02 | 2026-10-06 | 17 | $307.74 | $5.2K | 31,854 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2026-10-02 | 2026-10-06 | 235 | $307.19 | $72.2K | 31,871 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2026-10-02 | 2026-10-06 | 404 | $306.18 | $123.7K | 32,106 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2026-10-02 | 2026-10-06 | 1,535 | $304.52 | $467.4K | 32,510 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2026-10-02 | 2026-10-06 | 1,976 | $303.54 | $599.8K | 34,045 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2026-10-02 | 2026-10-06 | 833 | $302.51 | $252.0K | 36,021 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2026-10-02 | 2026-10-06 | 340 | $52.27 | $17.8K | 36,854 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2026-09-03 | 2026-09-08 | 400 | $288.98 | $115.6K | 36,514 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2026-09-03 | 2026-09-08 | 300 | $283.99 | $85.2K | 41,214 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2026-09-03 | 2026-09-08 | 2,115 | $286.36 | $605.7K | 37,299 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2026-09-03 | 2026-09-08 | 1,800 | $285.17 | $513.3K | 39,414 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2026-09-03 | 2026-09-08 | 385 | $287.53 | $110.7K | 36,914 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2026-09-03 | 2026-09-08 | 400 | $288.98 | $115.6K | 36,514 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2026-09-03 | 2026-09-08 | 385 | $287.53 | $110.7K | 36,914 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2026-09-03 | 2026-09-08 | 2,115 | $286.36 | $605.6K | 37,299 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2026-09-03 | 2026-09-08 | 1,800 | $285.17 | $513.3K | 39,414 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2026-09-03 | 2026-09-08 | 300 | $283.99 | $85.2K | 41,214 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2026-08-03 | 2026-08-04 | 5,000 | — | $0 | 29,444 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2026-08-03 | 2026-08-04 | 503 | $289.80 | $145.8K | 43,114 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2026-08-03 | 2026-08-04 | 356 | $288.75 | $102.8K | 43,617 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2026-08-03 | 2026-08-04 | 1,214 | $287.77 | $349.4K | 43,973 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2026-08-03 | 2026-08-04 | 1,032 | $286.80 | $296.0K | 45,187 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2026-08-03 | 2026-08-04 | 157 | $285.74 | $44.9K | 46,219 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2026-08-03 | 2026-08-04 | 33 | $284.55 | $9.4K | 46,376 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2026-08-03 | 2026-08-04 | 105 | $284.14 | $29.8K | 46,409 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2026-08-03 | 2026-08-04 | 5,000 | $52.27 | $261.4K | 46,514 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2026-08-03 | 2026-08-04 | 409 | $292.82 | $119.8K | 41,514 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2026-08-03 | 2026-08-04 | 991 | $291.71 | $289.1K | 41,923 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2026-08-03 | 2026-08-04 | 200 | $290.60 | $58.1K | 42,914 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2026-08-03 | 2026-08-04 | 5,000 | — | $0 | 29,444 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2026-08-03 | 2026-08-04 | 409 | $292.82 | $119.8K | 41,514 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2026-08-03 | 2026-08-04 | 991 | $291.71 | $289.1K | 41,923 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2026-08-03 | 2026-08-04 | 200 | $290.60 | $58.1K | 42,914 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2026-08-03 | 2026-08-04 | 503 | $289.80 | $145.8K | 43,114 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2026-08-03 | 2026-08-04 | 356 | $288.75 | $102.8K | 43,617 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2026-08-03 | 2026-08-04 | 1,214 | $287.77 | $349.4K | 43,973 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2026-08-03 | 2026-08-04 | 1,032 | $286.80 | $296.0K | 45,187 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2026-08-03 | 2026-08-04 | 157 | $285.74 | $44.9K | 46,219 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2026-08-03 | 2026-08-04 | 33 | $284.55 | $9.4K | 46,376 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2026-08-03 | 2026-08-04 | 105 | $284.14 | $29.8K | 46,409 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2026-08-03 | 2026-08-04 | 5,000 | $52.27 | $261.4K | 46,514 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2026-07-01 | 2026-07-06 | 5,000 | — | $0 | 34,444 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2026-07-01 | 2026-07-06 | 5,000 | $52.27 | $261.4K | 46,514 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2026-07-01 | 2026-07-06 | 396 | $308.99 | $122.4K | 46,118 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2026-07-01 | 2026-07-06 | 104 | $310.20 | $32.3K | 46,014 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2026-07-01 | 2026-07-06 | 1,119 | $311.72 | $348.8K | 44,895 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2026-07-01 | 2026-07-06 | 1,081 | $312.28 | $337.6K | 43,814 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2026-07-01 | 2026-07-06 | 700 | $313.46 | $219.4K | 43,114 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2026-07-01 | 2026-07-06 | 100 | $314.58 | $31.5K | 43,014 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2026-07-01 | 2026-07-06 | 900 | $315.78 | $284.2K | 42,114 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2026-07-01 | 2026-07-06 | 600 | $317.15 | $190.3K | 41,514 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | J Other | 2026-06-30 | 2026-07-06 | 132 | $160.71 | $21.2K | 41,514 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2026-06-01 | 2026-06-02 | 5,000 | — | $0 | 39,444 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2026-06-01 | 2026-06-02 | 1,216 | $229.47 | $279.0K | 41,582 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2026-06-01 | 2026-06-02 | 200 | $230.41 | $46.1K | 41,382 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2026-06-01 | 2026-06-02 | 584 | $228.57 | $133.5K | 42,798 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2026-06-01 | 2026-06-02 | 400 | $226.78 | $90.7K | 43,382 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2026-06-01 | 2026-06-02 | 1,432 | $225.97 | $323.6K | 43,782 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2026-06-01 | 2026-06-02 | 677 | $225.20 | $152.5K | 45,214 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2026-06-01 | 2026-06-02 | 491 | $223.95 | $110.0K | 45,891 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2026-06-01 | 2026-06-02 | 5,000 | $52.27 | $261.4K | 46,382 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2026-05-01 | 2026-05-04 | 5,000 | — | $0 | 44,444 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2026-05-01 | 2026-05-04 | 780 | $232.04 | $181.0K | 43,602 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2026-05-01 | 2026-05-04 | 600 | $227.45 | $136.5K | 45,782 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2026-05-01 | 2026-05-04 | 932 | $228.75 | $213.2K | 44,850 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2026-05-01 | 2026-05-04 | 800 | $234.02 | $187.2K | 41,382 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2026-05-01 | 2026-05-04 | 1,420 | $232.92 | $330.7K | 42,182 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2026-05-01 | 2026-05-04 | 5,000 | $52.27 | $261.4K | 46,382 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2026-05-01 | 2026-05-04 | 370 | $230.87 | $85.4K | 44,382 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2026-05-01 | 2026-05-04 | 98 | $229.71 | $22.5K | 44,752 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2026-04-01 | 2026-04-02 | 5,000 | — | $0 | 49,444 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2026-04-01 | 2026-04-02 | 337 | $204.50 | $68.9K | 41,382 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2026-04-01 | 2026-04-02 | 963 | $203.22 | $195.7K | 41,719 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2026-04-01 | 2026-04-02 | 700 | $201.90 | $141.3K | 42,682 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2026-04-01 | 2026-04-02 | 1,238 | $200.94 | $248.8K | 43,382 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2026-04-01 | 2026-04-02 | 1,302 | $199.72 | $260.0K | 44,620 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2026-04-01 | 2026-04-02 | 460 | $198.85 | $91.5K | 45,922 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2026-04-01 | 2026-04-02 | 5,000 | $52.27 | $261.4K | 46,382 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2026-03-04 | 2026-03-06 | 5,000 | — | $0 | 54,444 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2026-03-04 | 2026-03-06 | 300 | $201.70 | $60.5K | 41,069 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2026-03-04 | 2026-03-06 | 5,000 | $52.27 | $261.4K | 41,869 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2026-03-04 | 2026-03-06 | 1,446 | $208.12 | $300.9K | 38,011 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2026-03-04 | 2026-03-06 | 612 | $207.01 | $126.7K | 39,457 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2026-03-04 | 2026-03-06 | 340 | $206.37 | $70.2K | 40,069 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2026-03-04 | 2026-03-06 | 460 | $205.18 | $94.4K | 40,409 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2026-03-04 | 2026-03-06 | 200 | $204.17 | $40.8K | 40,869 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2026-03-04 | 2026-03-06 | 1,142 | $208.87 | $238.5K | 36,869 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2026-03-04 | 2026-03-06 | 93 | $200.62 | $18.7K | 41,369 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2026-03-04 | 2026-03-06 | 207 | $199.96 | $41.4K | 41,462 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2026-03-04 | 2026-03-06 | 100 | $199.01 | $19.9K | 41,669 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2026-03-04 | 2026-03-06 | 100 | $197.70 | $19.8K | 41,769 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award deriv | 2026-03-02 | 2026-03-27 | 21,525 | — | $0 | 21,525 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2026-03-02 | 2026-03-27 | 4,513 | — | $0 | 41,382 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | F Tax w/h | 2026-02-15 | 2026-02-18 | 992 | $183.83 | $182.4K | 36,869 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | F Tax w/h | 2026-02-15 | 2026-02-18 | 801 | $183.83 | $147.2K | 37,861 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | F Tax w/h | 2026-02-15 | 2026-02-18 | 593 | $183.83 | $109.0K | 38,662 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | F Tax w/h | 2026-02-14 | 2026-02-18 | 3,211 | $183.83 | $590.3K | 34,528 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2026-02-14 | 2026-02-18 | 8,810 | — | $0 | 43,338 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2026-02-14 | 2026-02-18 | 6,928 | — | $0 | 37,739 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | F Tax w/h | 2026-02-14 | 2026-02-18 | 4,083 | $183.83 | $750.6K | 39,255 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | F Tax w/h | 2025-08-10 | 2025-08-12 | 1,325 | $150.06 | $198.8K | 30,811 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | J Other | 2025-06-30 | 2025-07-02 | 233 | $91.08 | $21.2K | 32,136 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2025-06-23 | 2025-06-24 | 500 | $114.08 | $57.0K | 31,903 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2025-06-10 | 2025-06-12 | 500 | $114.54 | $57.3K | 32,403 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2025-05-15 | 2025-06-02 | 1,000 | $104.00 | $104.0K | 32,903 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award deriv | 2025-03-04 | 2025-03-06 | 28,043 | — | $0 | 28,043 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2025-03-04 | 2025-03-06 | 6,415 | — | $0 | 34,783 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | F Tax w/h | 2025-02-15 | 2025-02-19 | 1,114 | $120.00 | $133.7K | 29,244 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | F Tax w/h | 2025-02-15 | 2025-02-19 | 876 | $120.00 | $105.1K | 28,368 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2025-02-14 | 2025-02-19 | 6,928 | — | $0 | 29,462 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | F Tax w/h | 2025-02-14 | 2025-02-19 | 2,775 | $120.00 | $333.0K | 26,687 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2025-02-14 | 2025-02-19 | 5,429 | — | $0 | 32,116 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | F Tax w/h | 2025-02-14 | 2025-02-19 | 1,758 | $120.00 | $211.0K | 30,358 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2024-09-23 | 2024-09-25 | 2,000 | — | $0 | 70,944 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2024-09-23 | 2024-09-25 | 2,000 | $99.60 | $199.2K | 22,534 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2024-09-23 | 2024-09-25 | 2,000 | $52.27 | $104.5K | 24,534 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2024-08-28 | 2024-08-30 | 1,500 | — | $0 | 61,444 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2024-08-28 | 2024-08-30 | 1,500 | $52.27 | $78.4K | 24,034 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2024-08-28 | 2024-08-30 | 1,500 | $106.39 | $159.6K | 22,534 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | F Tax w/h | 2024-08-10 | 2025-06-02 | 897 | $100.16 | $89.8K | 21,637 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | J Other | 2024-06-28 | 2024-07-02 | 329 | $60.71 | $20.0K | 22,534 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2024-05-09 | 2024-05-13 | 10,000 | — | $0 | 62,944 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2024-05-09 | 2024-05-13 | 10,000 | $83.04 | $830.4K | 22,205 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2024-05-09 | 2024-05-13 | 10,000 | $52.27 | $522.7K | 32,205 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award deriv | 2024-02-27 | 2024-02-29 | 29,272 | — | $0 | 29,272 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2024-02-27 | 2024-02-29 | 7,208 | — | $0 | 22,205 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | F Tax w/h | 2024-02-15 | 2024-02-16 | 593 | $74.65 | $44.3K | 14,997 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | J Other | 2023-12-29 | 2024-01-04 | 179 | $60.71 | $10.9K | 15,590 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | F Tax w/h | 2023-08-10 | 2023-08-14 | 897 | $68.73 | $61.7K | 15,411 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2023-03-24 | 2023-03-28 | 300 | $69.92 | $21.0K | 16,308 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award deriv | 2023-02-23 | 2023-02-27 | 15,393 | — | $0 | 15,393 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2023-02-23 | 2023-02-27 | 5,668 | — | $0 | 16,608 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | F Tax w/h | 2022-11-30 | 2022-12-01 | 1,073 | $72.90 | $78.2K | 10,940 | SEC↗ |